Silver Nanoparticles as Alternative to Aspirin: Shows Great Promise in Clot Prevention

June 2, 2009

(ChattahBox)—Deep Vein Thrombosis and a resulting Pulmonary Embolism are serious, often fatal conditions, affecting from 350,000 to 600,000 Americans every year and responsible for at least 100,000 deaths. Many heart patients rely on the use of aspirin or other anti-clotting medications to prevent life threatening blood clots, but a significant number of patients are unable to tolerate aspirin.

A new study successfully used nanoparticles of silver injected in mice as a promising alternative to aspirin products, which has the potential to save lives.

Scientists from the Department of Biochemistry, Institute of Medical Sciences, Banaras Hindu University, began their valuable research to find a safe replacement for aspirin that causes stomach bleeding in many patients.

Sedentary lifestyles and the aging of the population has increased the need for alternative medications to prevent blood clots, as the instance of Thrombotic disorders has increased at alarming levels.

The researchers injected low levels of the silver nanoparticles into mice, which resulted in the reduction of the blood platelets to clot, by 40 percent with no apparent harmful side effects. The nanoparticles are 1/50,000th the diameter of a single strand of human hair.

The researchers are confident that the use of silver nanoparticles shows great potential as antiplatelet agents. Further research isĀ  needed to study the potential toxicity of the silver particles, before the new treatment can be tested on humans.

The study is available in the recent issue of the Journal of the American Chemical Society.



One Response to “Silver Nanoparticles as Alternative to Aspirin: Shows Great Promise in Clot Prevention”

  1. Silver Nanoparticles as Alternative to Aspirin: Shows Great … on June 2nd, 2009 1:10 pm

    […] po­st: S­il­ve­r N­an­op­artic­l­e­s­ as­ Al­te… Share and […]

Got something to say? **Please Note** - Comments may be edited for clarity or obscenity, and all comments are published at the discretion of - Comments are the opinions of the individuals leaving them, and not of or its partners. - Please do not spam or submit comments that use copyright materials, hearsay or are based on reports where the supposed fact or quote is not a matter of public knowledge are also not permitted.